Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,6-Bis(2-benzimidazolyl)pyridine is a V-shaped ligand that acts as a tridentate nitrogen donor, capable of forming complexes with various compounds. It is known for its ability to serve as an efficient anion receptor, providing chemical shift and optical modification based signals for the detection of specific ions and molecules.

28020-73-7

Post Buying Request

28020-73-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

28020-73-7 Usage

Uses

Used in Chemical Sensing Applications:
2,6-Bis(2-benzimidazolyl)pyridine is used as a chemosensor for the detection of fluoride ions, which are essential for various biological processes but can be harmful in high concentrations. Its ability to detect toxic metabolites of benzene, such as phenol, hydroquinone, resorcinol, catechol, and p-benzoquinone, makes it a valuable tool in environmental monitoring and industrial safety.
Used in Anion Recognition:
As an efficient anion receptor, 2,6-bis(2-benzimidazolyl)pyridine is employed for the detection of acetate ions. This application is crucial in various fields, including water quality assessment, pharmaceutical analysis, and chemical research.
Used in Optical Sensing:
2,6-Bis(2-benzimidazolyl)pyridine is also reported as an optical sensor useful for the recognition of aniline, an important chemical intermediate in the synthesis of various polymers, dyes, and pharmaceuticals. Its ability to detect aniline can be beneficial in monitoring industrial processes and ensuring product quality.
Used in Complex Formation:
The ligand reacts with UO2Cl2·3THF to form complexes, which can be useful in various chemical and materials science applications, such as nuclear fuel reprocessing, catalysis, and the development of new materials with unique properties.

Check Digit Verification of cas no

The CAS Registry Mumber 28020-73-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,0,2 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 28020-73:
(7*2)+(6*8)+(5*0)+(4*2)+(3*0)+(2*7)+(1*3)=87
87 % 10 = 7
So 28020-73-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H13N5/c1-2-7-13-12(6-1)21-18(22-13)16-10-5-11-17(20-16)19-23-14-8-3-4-9-15(14)24-19/h1-11H,(H,21,22)(H,23,24)

28020-73-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B3510)  2,6-Bis(2-benzimidazolyl)pyridine  >98.0%(HPLC)

  • 28020-73-7

  • 1g

  • 705.00CNY

  • Detail
  • TCI America

  • (B3510)  2,6-Bis(2-benzimidazolyl)pyridine  >98.0%(HPLC)

  • 28020-73-7

  • 5g

  • 2,650.00CNY

  • Detail
  • Aldrich

  • (379433)  2,6-Bis(2-benzimidazolyl)pyridine  

  • 28020-73-7

  • 379433-1G

  • 785.07CNY

  • Detail

28020-73-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[6-(1H-benzimidazol-2-yl)pyridin-2-yl]-1H-benzimidazole

1.2 Other means of identification

Product number -
Other names 2,2'-(2,6-Pyridinediyl)bis(benzimidazole)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:28020-73-7 SDS

28020-73-7Synthetic route

Pyridine-2,6-dicarboxylic acid
499-83-2

Pyridine-2,6-dicarboxylic acid

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

Conditions
ConditionsYield
With phosphoric acid at 220℃; for 4h;96%
With polyphosphoric acid at 200℃; for 6h;95%
With phosphoric acid at 220℃; for 5h;92%
2,6-bis{[(2-aminophenyl)imino]methyl}pyridine

2,6-bis{[(2-aminophenyl)imino]methyl}pyridine

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

Conditions
ConditionsYield
With iodine In methanol; dichloromethane for 5h;94%
Cu(OAc)2*2,6-bis(benzoimidazolyl)pyridine

Cu(OAc)2*2,6-bis(benzoimidazolyl)pyridine

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

Conditions
ConditionsYield
With sodium sulfide In methanol for 0.5h;85%
[Cu(2,6-bis(1H-benzo[d]imidazol-2-yl)pyridine)(H2O)2](SO3CF3)2

[Cu(2,6-bis(1H-benzo[d]imidazol-2-yl)pyridine)(H2O)2](SO3CF3)2

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

Conditions
ConditionsYield
With L-Cysteine In aq. buffer at 25℃; for 1h; pH=7.34; Concentration; Time; Inert atmosphere;
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

UO2Cl2(THF)3

UO2Cl2(THF)3

[UO2(H2BBP)Cl2]

[UO2(H2BBP)Cl2]

Conditions
ConditionsYield
With pyridine for 1h; Inert atmosphere;98%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

2,6-bis(5-nitro-1H-benzo[d]imidazol-2-yl)pyridine
866604-68-4

2,6-bis(5-nitro-1H-benzo[d]imidazol-2-yl)pyridine

Conditions
ConditionsYield
With sulfuric acid; nitric acid for 4h; Cooling with ice;97%
ferrous(II) sulfate heptahydrate

ferrous(II) sulfate heptahydrate

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

ammonium hexafluorosilicate

ammonium hexafluorosilicate

iron (II) hexafluorosilicate

iron (II) hexafluorosilicate

Conditions
ConditionsYield
With ascorbic acid In ethanol96%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

diethyl (4-bromobutyl)phosphonate
63075-66-1

diethyl (4-bromobutyl)phosphonate

2,6-bis(1-(4-diethylphosphonyl)butylbenzimidazol-2-yl)pyridine

2,6-bis(1-(4-diethylphosphonyl)butylbenzimidazol-2-yl)pyridine

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 100℃; for 10h;95%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

AuCl4H4(1-)*K(1+)

AuCl4H4(1-)*K(1+)

C19H11AuClN5(1+)

C19H11AuClN5(1+)

Conditions
ConditionsYield
With sodium acetate In methanol for 2h; Reflux;95%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

potassium tetrachloroaurate(III)

potassium tetrachloroaurate(III)

water
7732-18-5

water

C19H11AuClN5*H2O
1431846-31-9

C19H11AuClN5*H2O

Conditions
ConditionsYield
With sodium acetate In methanol for 2h; Reflux;95%
ferrous(II) sulfate heptahydrate

ferrous(II) sulfate heptahydrate

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

B10H10(2-)*2K(1+)*2H2O

B10H10(2-)*2K(1+)*2H2O

[Fe(II)(2,6-bis(benzimidazol-2-yl)pyridine)2]*[B10H10]*2H2O

[Fe(II)(2,6-bis(benzimidazol-2-yl)pyridine)2]*[B10H10]*2H2O

Conditions
ConditionsYield
With ascorbic acid In ethanol; water for 5h; Heating;95%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

potassium tetrachloroaurate(III)

potassium tetrachloroaurate(III)

C19H11AuClN5

C19H11AuClN5

Conditions
ConditionsYield
Stage #1: 2,6-bis(benzimidazole-2'-yl)pyridine With sodium acetate In methanol at 50℃; for 0.5h;
Stage #2: potassium tetrachloroaurate(III) In methanol at 50℃; for 12h;
94%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

zinc(II) nitrate hexahydrate

zinc(II) nitrate hexahydrate

water
7732-18-5

water

saccharin sodium salt
128-44-9

saccharin sodium salt

[zinc(II)(2,6-bis(2-benzimidazolyl)pyridine)2](saccharinate)2 dihydrate

[zinc(II)(2,6-bis(2-benzimidazolyl)pyridine)2](saccharinate)2 dihydrate

Conditions
ConditionsYield
In methanol at 60℃; for 4h;94%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

iron(II) bromide

iron(II) bromide

2,6-bis(2-benzimidazolyl)pyridine iron dibromide
1184194-98-6

2,6-bis(2-benzimidazolyl)pyridine iron dibromide

Conditions
ConditionsYield
In tetrahydrofuran (Ar); std. Schlenk technique; mixt. of ligand and FeBr2 in THF was stirred at room temp. for 1 h and at 60°C for 4 h; cooled to room temp.; filtered; washed (Et2O); dried (vac.); elem. anal.;93%
oxovanadium(IV) sulfate

oxovanadium(IV) sulfate

2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

VO(2,6-bis(benzimidazolyl)pyridine)(H2O)(SO4)

VO(2,6-bis(benzimidazolyl)pyridine)(H2O)(SO4)

Conditions
ConditionsYield
In ethanol Reflux;93%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

water
7732-18-5

water

saccharin sodium salt
128-44-9

saccharin sodium salt

copper dichloride

copper dichloride

[Cu(saccharinate)2(2,6-bis(2-benzimidazolyl)pyridine)]*3DMF

[Cu(saccharinate)2(2,6-bis(2-benzimidazolyl)pyridine)]*3DMF

Conditions
ConditionsYield
In methanol at 55℃; for 4h;93%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

chromium(III) chloride
10025-73-7

chromium(III) chloride

[2,6-bis(2-benzimidazolyl)pyridyl]chromium(III) chloride
307990-84-7

[2,6-bis(2-benzimidazolyl)pyridyl]chromium(III) chloride

Conditions
ConditionsYield
With Zn-Hg amalgam In ethanol CrCl3 placed in filter thimble of Soxhlet extractor with Zn-Hg amalgam and soln. of ligand added to reservoir flask, N2 bubbled for 10 min before heating, then CrCl3 extd.; filtered with vac., elem. anal.;92.6%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

manganese (II) nitrate tetrahydrate

manganese (II) nitrate tetrahydrate

water
7732-18-5

water

saccharin sodium salt
128-44-9

saccharin sodium salt

[Mn(NO3)(saccharinate)(H2O)(2,6-bis(2-benzimidazolyl)pyridine)]*2DMF

[Mn(NO3)(saccharinate)(H2O)(2,6-bis(2-benzimidazolyl)pyridine)]*2DMF

Conditions
ConditionsYield
In methanol at 55℃; for 4h;92%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

water
7732-18-5

water

copper(II) bis(trifluoromethanesulfonate)
34946-82-2

copper(II) bis(trifluoromethanesulfonate)

[Cu(2,6-bis(1H-benzo[d]imidazol-2-yl)pyridine)(H2O)2](SO3CF3)2

[Cu(2,6-bis(1H-benzo[d]imidazol-2-yl)pyridine)(H2O)2](SO3CF3)2

Conditions
ConditionsYield
In methanol at 55℃; for 0.5h; Inert atmosphere;91.4%
2,6-bis(benzimidazole-2'-yl)pyridine
28020-73-7

2,6-bis(benzimidazole-2'-yl)pyridine

cadmium chloride tetrahydrate

cadmium chloride tetrahydrate

Cd(C5NH3(C7N2H5)2)Cl2*H2O

Cd(C5NH3(C7N2H5)2)Cl2*H2O

Conditions
ConditionsYield
In methanol a methanol soln. of the ligand was added to a methanol soln. of the Cd salt at room temp.; filtered, washed with methanol, acetone, ether, dried in a vac. desiccator over P4O10; elem. anal.;91%

28020-73-7Relevant articles and documents

Synthesis and crystal structure of a 3-D netlike supramolecular cobalt picrate complex with 2, 6-bis(benzimidazol-2-yl)pyridine

Yan, Zhen-Zhong,Hou, Na,Liang, Hua-Ding

, p. 344 - 347 (2014)

A novel complex of cobalt picrate with 2, 6-bis(benzimidazol-2-yl)pyridine (L), has been prepared and characterized by elemental analysis, IR spectroscopy, and single-crystal X-ray diffraction. The complex crystallizes in the monoclinic system, space group c2/c with a = 21.8756(6) A, b = 12.2995(3) A, c = 27.4827(7) A, β = 95.6060(10)°, and Z = 4. The structure was refined to the final R1 = 0.0708. The complex units are linked by π-π interactions and hydrogen bonds to give infinite two-dimensional (2-D) supramolecular layers, which are further linked by the intermolecular hydrogen bonds to form a three-dimensional (3-D) netlike supramolecule. Copyright Taylor & Francis Group, LLC.

Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand

Aghatabay, Naz M.,Neshat,Karabiyik,Somer,Haciu,Duelger

, p. 205 - 213 (2007)

2,6-Bis(benzimidazol-2-yl)pyridine (L) ligand and complexes [M(L)Cl2] and [Fe(L)2](ClO4)2 (M = Zn, Cd, Hg) have been synthesized. The geometries of the [M(L)Cl2] complexes were derived from theoretical calculation in DGauss/DFT level (DZVP basis set) on CACHE. The central M(II) ion is penta-coordinated and surrounded by N3Cl2 environment, adopting a distorted trigonal bipyramidal geometry. The ligand is tridentate, via three nitrogen atoms to metal centre and two chloride ions lie on each side of the distorted benzimidazole ring. In the [Fe(L)2](ClO4)2 complex, the central Fe(II) ion is surrounded by two (3N) units, adopting a octahedral geometry. The elemental analysis, molecular conductivity, FT-Raman, FT-IR (mid-, far-IR), 1H, and 13C NMR were reported. The antimicrobial activities of the free ligand, its hydrochloride salt, and the complexes were evaluated using the disk diffusion method in dimethyl sulfoxide (DMSO) as well as the minimal inhibitory concentration (MIC) dilution method, against 10 bacteria and the results compared with that for gentamycin. Antifungal activities were reported for Candida albicans, Kluyveromyces fragilis, Rhodotorula rubra, Debaryomyces hansenii, Hanseniaspora guilliermondii, and the results were referenced against nystatin, ketaconazole, and clotrimazole antifungal agents. In most cases, the compounds tested showed broad-spectrum (Gram positive and Gram negative bacteria) activities that were either more effective than or as potent as the references. The binding of two most biologically effective compounds of zinc and mercury to calf thymus DNA has also been investigated by absorption spectra.

Probing the Effects of Ligand Field and Coordination Geometry on Magnetic Anisotropy of Pentacoordinate Cobalt(II) Single-Ion Magnets

Mondal, Amit Kumar,Goswami, Tamal,Misra, Anirban,Konar, Sanjit

, p. 6870 - 6878 (2017)

In this work, the effects of ligand field strength as well as the metal coordination geometry on magnetic anisotropy of pentacoordinated CoII complexes have been investigated using a combined experimental and theoretical approach. For that, a strategic design and synthesis of three pentacoordinate CoII complexes [Co(bbp)Cl2]·(MeOH) (1), [Co(bbp)Br2]·(MeOH) (2), and [Co(bbp)(NCS)2] (3) has been achieved by using the tridentate coordination environment of the ligand in conjunction with the accommodating terminal ligands (i.e., chloride, bromide, and thiocyanate). Detailed magnetic studies disclose the occurrence of slow magnetic relaxation behavior of CoII centers with an easy-plane magnetic anisotropy. A quantitative estimation of ZFS parameters has been successfully performed by density functional theory (DFT) calculations. Both the sign and magnitude of ZFS parameters are prophesied well by this DFT method. The theoretical results also reveal that the α → β (SOMO-SOMO) excitation contributes almost entirely to the total ZFS values for all complexes. It is worth noting that the excitation pertaining to the most positive contribution to the ZFS parameter is the dxy → dx2-y2 excitation for complexes 1 and 2, whereas for complex 3 it is the dz2 → dx2-y2 excitation.

Stimuli-Responsive Cycloaurated “OFF-ON” Switchable Anion Transporters

Fares, Mohamed,Gale, Philip A.,Howe, Ethan N. W.,Keller, Paul A.,Lewis, William,Pérez-Tomás, Ricardo,Ramesh, Deepthi,Wu, Xin

, p. 17614 - 17621 (2020)

Anion transporters have shown potential application as anti-cancer agents that function by disrupting homeostasis and triggering cell death. In this research article we report switchable anion transport by gold complexes of anion transporters that are “switched on” in situ in the presence of the reducing agent GSH by decomplexation of gold. GSH is found in higher concentrations in tumors than in healthy tissue and hence this approach offers a strategy to target these systems to tumors.

Rational design of ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives with radiosensitization activity by enhancing p53 activation

Deng, Zhiqin,Yu, Lianling,Cao, Wenqiang,Zheng, Wenjie,Chen, Tianfeng

, p. 991 - 998 (2015)

Abstract The rational design of metal-based complexes is an effective strategy for the discovery of potent sensitizers for use in cancer radiotherapy. In this study, we synthesized three ruthenium complexes containing bis-benzimidazole derivatives: Ru(bbp)Cl3 (1), [Ru(bbp)2]Cl2 (2 a) (in which bbp=2,6-bis(benzimidazol-1-yl)pyridine), and [Ru(bnbp)2]Cl2 (2 b) (where bnbp=2,6-bis-(6-nitrobenzimidazol-2-yl)pyridine). We evaluated their radiosensitization capacities in vitro and mechanisms of action. Complex 2 b was found to be particularly effective in sensitizing human melanoma A375 cells toward radiation, with a sensitivity enhancement ratio of 2.4. Along with this potency, complex 2 b exhibited a high degree of selectivity between human cancer and normal cells. Mechanistic studies revealed that 2 b promotes radiation-induced accumulation of intracellular reactive oxygen species (ROS) by reacting with cellular glutathione (GSH) and then causing DNA stand breaks. The subsequent DNA damage induces phosphorylation of p53 (p-p53) and upregulates the expression levels of p21, which inhibits the expression of cyclin-B, leading to G2M arrest. Moreover, p-p53 activates caspases-3 and -8, triggers cleavage of poly(ADP-ribose) polymerase (PARP), finally resulting in apoptosis. Taken together, the results of this study provide a strategy for the design of ruthenium-based radiosensitizers for use in cancer therapy.

A simple 2,6-bis(2-benzimidazole)pyridyl incorporated optical probe affording selective ratiometric targeting of biologically and environmentally significant Zn2+ under buffer condition

Mashraqui, Sabir H.,Chandiramani, Mukesh,Ghorpade, Sushil,Upathayay, Jyoti,Mestri, Rupesh,Chilekar, Aniket

, p. 129 - 135 (2016)

A new chemosensor, designated as Dibcid has been synthesized in two steps from readily accessible 2,6-bis(2-benzimidazole)pyridine. Our photophysical studies revealed that of the several metal ions examined, biologically and environmentally significant Zn2+ exhibited highly selective emission wavelength shifts under the buffer condition. In contrast to Zn2+, the coordinatively competing and toxic Cd2+ elicited less remarkable optical responses as evidenced by its two order of magnitude lower stability constant compared to that of Zn2+. Moreover, metal ions, viz. Li+, Na+, K+, Mg2+, Ca2+, Ba2+, Co2+, Ni2+, Cu2+, Hg2+ and Pb2+ exhibited insignificant optical perturbations even in concentrations far exceeding Zn2+. Clearly, the probe has the attributes to selectively target Zn2+ by ratiometric analysis under buffer conditions.

Toward equatorial planarity about uranyl: Synthesis and structure of tridentate nitrogen-donor {UO2}2+ complexes

Copping, Roy,Jeon, Byoungseon,Pemmaraju, C. Das,Wang, Shuao,Teat, Simon J.,Janousch, Markus,Tyliszczak, Tolek,Canning, Andrew,Gronbech-Jensen, Niels,Prendergast, David,Shuh, David K.

, p. 2506 - 2515 (2014)

The reaction of UO2Cl2·3THF with the tridentate nitrogen donor ligand 2,6-bis(2-benzimidazolyl)pyridine (H 2BBP) in pyridine leads to the formation of three different complexes: [(UO2)(H2BBP)Cl2] (1), [(UO) 2(HBBP)(Py)Cl] (2), and [(UO2)(BBP)(Py)2] (3) after successive deprotonation of H2BBP with a strong base. Crystallographic determination of 1-3 reveals that increased charge through ligand deprotonation and displacement of chloride leads to equatorial planarity about uranyl as well as a more compact overall coordination geometry. Near-Edge X-ray Absorption Fine Structure (NEXAFS) spectra of 1-3 at the U-4d edges have been recorded using a soft X-ray Scanning Transmission X-ray Microscope (STXM) and reveal the uranium 4d5/2 and 4d3/2 transitions at energies associated with uranium in the hexavalent oxidation state. First-principles Density Functional Theory (DFT) electronic structure calculations for the complexes have been performed to determine and validate the coordination characteristics, which correspond well to the experimental results.

Low spin Fe(II) complexes formed of monosubstitued 2,6-bis(2-benzimidazolyl)pyridine ligands

Rajnák, Cyril,Titi?, Ján,Fuhr, Olaf,Ruben, Mario,Bo?a, Roman

, p. 122 - 131 (2017)

Five ligands as monosubstituted derivatives of the basic skeleton of 2,6-bis(2-benzimidazyl)pyridine were synthesized, and characterized by NMR and IR spectra along with the X-ray structure analysis. Their complexation gave a set of hexacoordinate Fe(II) complexes showing predominantly the diamagnetism until ambient temperature. Some temperature-independent paramagnetism along with an onset of the spin transition is also detected.

Synthesis, structure, and supramolecular chemistry of three azide manganese complexes with 2, 6-Bis(benzimidazol-2-yl)pyridine

Wang, Chuan-Feng,Dai, Guo-Liang,Jin, Zheng-Neng,He, Zhi-Cai

, p. 1340 - 1344 (2012)

Three azide complexes with the tridentate ligand 2, 6-bis(benzimidazol-2- yl)pyridine (H2BBIP) were synthesized and their complicated supramolecular interactions were investigated with single-crystal X-ray diffraction. Interestingly, the complexes are assembled by bifurcated hydrogen bonding, double helical π-π stacking, or anion-π stacking interactions of the benzimidazole rings by tuning the reaction conditions (temperature, ratio, solvent). Complex 1 is a mononuclear compound, namely, Mn(H 2BBIP)N3(CH3O)·CH3OH. In its 3D supramolecular network, the nitrogen atom of the azide anion is acting as hydrogen bonding bifurcated acceptor. Complex 2 is a dinuclear compound, namely, Mn2(H2BBIP)2(N3) 2·(H2O)0.5. The dinuclear unit is connected by intramolecular π-π stacking interactions. Furthermore, double helical π-π stacking interactions in the benzimidazole rings are observed. Complex 3, Mn2(H2BBIP)2(N 3)2·CH3OH, can be formulated as a pseudopolymorph of complex 2, which exhibits intramolecular π-π stacking interactions as well as anion-π interactions in the dinuclear unit. Copyright

Concise design and synthesis of water-soluble fluorescence sensor for sequential detection of Zn(II) and picric acid via cascade mechanism

Jiang, Kai,Chen, Si-Hong,Luo, Shi-He,Pang, Chu-Ming,Wu, Xin-Yan,Wang, Zhao-Yang

, p. 164 - 173 (2019)

Under microwave assistance, 2,6-bis(benzimidazolyl)-pyridine has been concisely synthesized and further productively converted to the functional molecule BMBP via accessible N-alkylation reaction. For the introduction of alkoxyalkyl chain, this original substance BMBP with better solubility in water exhibits specific fluorescence response toward Zn2+ from colourless to blue in aqueous solution. A sequential detection for picric acid (PA) can be conducted in this following system, showing the high selectivity and sensitivity of quenching over other analogues. On the basis of the comparison with the control BMBB, a cascade sensing mechanism has been disclosed to accelerate the recognition of structure-property relationship, which is fully supported by LC-MS, 1H NMR, lifetime measurement and theoretical calculation. Noteworthily, BMBP is also readily available for practical application not only in quantitative determination of Zn2+ and PA in real water samples, but also in visible detection of two analytes in multiple forms on paper test strips, offering convenient process for low-cost, portable and versatile sensing device.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 28020-73-7